SAN JOSE, Calif., April 14, 2016 -- Vocera Communications, Inc. (NYSE:VCRA) today announced that it expects to release results for its first quarter 2016 on Thursday, April 28, after market close. In conjunction with a press release, management will host a conference call at 5 p.m. ET that afternoon.
A free, live webcast of the conference call will be available on the Investors section of the company’s website at investors.vocera.com.
The call also can be accessed by dialing 855-307-5251, or 440-996-5719 for international callers, and using the access code 70546778.
A replay of the call will be archived on the company’s website.
About Vocera
Vocera Communications, Inc. offers the most robust clinical communications system in healthcare. Installed in more than 1,300 organizations worldwide, Vocera delivers secure, integrated and intelligent communication solutions that enable care teams to collaborate more efficiently by delivering the right information, to the right person, on the right device, in the right location, at the right time. Vocera solutions provide hands-free voice communication, secure text messaging, patient engagement tools, and integrated clinical workflow with EHRs, nurse call systems and physiological monitors. These solutions help improve operational efficiency, quality of care, safety and satisfaction across the continuum of care. In addition to technology solutions, Vocera drives thought leadership and new standards in care to elevate patient, family, nurse and physician experiences via the company's research collaborative, the Experience Innovation Network. Vocera is headquartered in San Jose, California, with offices in San Francisco, Tennessee, Canada, India, United Arab Emirates and the United Kingdom. For more information, visit www.vocera.com and @VoceraComm on Twitter.
The Vocera logo is a trademark of Vocera Communications, Inc. Vocera® is a trademark of Vocera Communications, Inc. registered in the United States and other jurisdictions. All other trademarks appearing in this release are the property of their respective owners.
CONTACTS: Investors and Analysts: Sue Dooley Vocera 408.882.5971 [email protected] Media: Jessica Donnelly Edelman 323-202-1051 [email protected]


Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 



